ArticleApplied biochemistry and biotechnology2026
YTHDC1 Inhibits Esophageal Cancer Cell Apoptosis, Radiosensitivity and Autophagy Via Upregulating PLK1 by Stabilizing USP10.
Article in Applied biochemistry and biotechnology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundYTH domain-containing protein 1 (YTHDC1) has been confirmed to be involved in regulating esophageal cancer (EC) progression. However, whether YTHDC1 mediates the radioresistance of EC and its potential molecular mechanism still need to be further explored.
methodsThe mRNA and protein levels of YTHDC1, ubiquitin-specific peptidase 10 (USP10) and polo-like kinase 1 (PLK1) were determined by qRT-PCR and western blot. Cell proliferation, invasion, migration, radiosensitivity, and apoptosis were detected by CCK8 assay, transwell assay, colony formation assay, and flow cytometry. The level of autophagy-related marker LC3B was examined using western blot. The interaction between USP10 and YTHDC1 or PLK1 was assessed by RIP assay, Co-IP assay and ubiquitination assay. Animal experiments were performed to explore the role of YTHDC1 in vivo.
resultsYTHDC1 was increased expression in EC tissues and cells. Silencing of YTHDC1 suppressed EC cell proliferation, migration and invasion, while promoted apoptosis, radiosensitivity and autophagy. YTHDC1 could stabilize USP10 mRNA level, and USP10 increased PLK1 expression by deubiquitination. Further analysis showed that PLK1 overexpression reversed the regulation of YTHDC1 knockdown on EC cell proliferation, invasion, radiosensitivity and autophagy. Besides, YTHDC1 knockdown could inhibit EC tumorigenesis and improve radiosensitivity in vivo via inactivating USP10/PLK1 axis.
conclusionTargeted inhibition of YTHDC1/USP10/PLK1 axis may be an effective measure to inhibit EC progression and improve radiosensitivity.
Indexed as
Identifiers
41579257What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.